EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management

Bahareh Hassanzadeh, Jeffrey DeSanto, Jorge C Kattah

Neuro-Ophthalmology · 04.05.2018 · 42 (3) · 176-181

DOI: 10.1080/01658107.2017.1368090 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuro-Ophthalmology, online erschienen am 20.09.2017. Verfasst von Bahareh Hassanzadeh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ipilimumab is a novel anti-melanoma agent known to infrequently cause multi-organ autoimmunity. We report a case of pituitary hypophysitis and orbital inflammation followed by an orbital apex syndrome. A 64-year-old woman with a history of skin melanoma, receiving ipilimumab treatment, was seen for near total loss of vision in the right eye and proptosis. Headache of 3-month duration preceded the onset of diplopia followed by severe loss of vision in the right eye. Neuro-ophthalmologic examination was consistent with an orbital apex syndrome. Extensive blood work and magnetic resonance imaging of the brain and orbit suggested an inflammatory process, rather than a metastatic lesion. Accordingly, the patient received high-dose methylprednisolone followed by tapering oral prednisone. At the 6-month follow-up visit, visual acuity on the right eye had significantly improved but diplopia remained, associated with large amplitude esotropia that improved incompletely though while on prednisone. The favourable outcome supported a final diagnosis of ipilimumab-induced inflammatory orbital apex syndrome and clinically silent pituitary adenohypophysitis. The case presented herein highlights unexpected ipilimumab-associated adverse effects and proposes the possibility of and interaction between inflammatory and immune mechanisms.

Schlagwörter

Stichwörter der Autor:innen

Adenohypophysitisipilimumaborbital apex syndrome

Autor:innen und Institutionen

  • Department of Neurology, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA.
  • OSF HealthCare Illinois Neurological Institute, Peoria, Illinois, USA.

Zitieren

APA

Hassanzadeh, B., DeSanto, J., & Kattah, J. C. (2018). Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management. Neuro-Ophthalmology, 42(3), 176-181. https://doi.org/10.1080/01658107.2017.1368090

Vancouver

Hassanzadeh B, DeSanto J, Kattah JC. Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management. Neuro-Ophthalmology. 2018;42(3):176-181. doi:10.1080/01658107.2017.1368090

BibTeX
@article{Hassanzadeh2018,
  author = {Hassanzadeh, Bahareh and DeSanto, Jeffrey and Kattah, Jorge C},
  title = {Ipilimumab-induced Adenohypophysitis and Orbital Apex Syndrome: Importance of Early Diagnosis and Management},
  journal = {Neuro-Ophthalmology},
  year = {2018},
  volume = {42},
  number = {3},
  pages = {176--181},
  doi = {10.1080/01658107.2017.1368090}
}
Kostenlos starten →